Occudo Quantitative Strategies’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,241
Closed -$456K 884
2023
Q4
$456K Sell
2,241
-6,304
-74% -$1.02M 0.06% 427
2023
Q3
$1.7M Buy
8,545
+7,599
+803% +$1.92M 0.22% 122
2023
Q2
$307K Buy
+946
New +$270K 0.03% 734
2023
Q1
Sell
-2,683
Closed -$676K 1037
2022
Q4
$676K Sell
2,683
-4,412
-62% -$941K 0.08% 402
2022
Q3
$1.26M Buy
7,095
+5,351
+307% +$1.08M 0.1% 314
2022
Q2
$319K Sell
1,744
-1,224
-41% -$244K 0.03% 770
2022
Q1
$762K Hold
2,968
0.06% 474
2021
Q4
$683K Sell
2,968
-353
-11% -$86.2K 0.06% 497
2021
Q3
$773K Sell
3,321
-130
-4% -$27.1K 0.09% 386
2021
Q2
$667K Hold
3,451
0.1% 328
2021
Q1
$714K Sell
3,451
-2,464
-42% -$524K 0.16% 220
2020
Q4
$1.11M Buy
+5,915
New +$967K 0.35% 51

Other funds holding INSP

Occudo Quantitative Strategies's INSP Position: Q1 2024 in Review

Occudo Quantitative Strategies sold out of Inspire Medical Systems (INSP) in Q1 2024, closing a stake of 2,241 shares — an estimated $456K sold.

Occudo Quantitative Strategies first reported a position in INSP in Q4 2020 and held it in 12 quarters. The position peaked at $1.7M in Q3 2023. 328 funds tracked by Wall St. Rank hold INSP as of Q1 2024.

  • Occudo Quantitative Strategies reported no remaining Inspire Medical Systems position as of Q1 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 2,241 Inspire Medical Systems shares in Q1 2024, an estimated $456K.
  • Occudo Quantitative Strategies first reported a position in Inspire Medical Systems in Q4 2020 and held it in 12 quarters.
  • Occudo Quantitative Strategies's Inspire Medical Systems position peaked at $1.7M in Q3 2023.
  • 328 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2024, filed 15 May 2024.